nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2D6—Carteolol—glaucoma	0.0912	0.17	CbGbCtD
Loperamide—CYP2D6—Betaxolol—glaucoma	0.0616	0.115	CbGbCtD
Loperamide—CYP2D6—Methazolamide—glaucoma	0.0467	0.0869	CbGbCtD
Loperamide—CYP3A4—Pilocarpine—glaucoma	0.044	0.0818	CbGbCtD
Loperamide—ABCB1—Timolol—glaucoma	0.0421	0.0784	CbGbCtD
Loperamide—CYP2D6—Timolol—glaucoma	0.0397	0.0739	CbGbCtD
Loperamide—ABCB1—Clonidine—glaucoma	0.0358	0.0667	CbGbCtD
Loperamide—CYP3A4—Brinzolamide—glaucoma	0.0345	0.0642	CbGbCtD
Loperamide—CYP2D6—Clonidine—glaucoma	0.0338	0.0628	CbGbCtD
Loperamide—CYP3A4—Dorzolamide—glaucoma	0.0333	0.062	CbGbCtD
Loperamide—CYP3A4—Methazolamide—glaucoma	0.0297	0.0552	CbGbCtD
Loperamide—CYP3A4—Acetazolamide—glaucoma	0.0237	0.0442	CbGbCtD
Loperamide—CYP3A4—Clonidine—glaucoma	0.0215	0.0399	CbGbCtD
Loperamide—Rash—Metipranolol—glaucoma	0.00104	0.00365	CcSEcCtD
Loperamide—Skin disorder—Apraclonidine—glaucoma	0.00104	0.00365	CcSEcCtD
Loperamide—Dermatitis—Metipranolol—glaucoma	0.00104	0.00365	CcSEcCtD
Loperamide—Drowsiness—Clonidine—glaucoma	0.00104	0.00364	CcSEcCtD
Loperamide—Asthenia—Levobunolol—glaucoma	0.00104	0.00363	CcSEcCtD
Loperamide—Headache—Metipranolol—glaucoma	0.00103	0.00363	CcSEcCtD
Loperamide—Pruritus—Levobunolol—glaucoma	0.00102	0.00358	CcSEcCtD
Loperamide—Nervous system disorder—Bimatoprost—glaucoma	0.00102	0.00357	CcSEcCtD
Loperamide—Dizziness—Carteolol—glaucoma	0.00101	0.00355	CcSEcCtD
Loperamide—Skin disorder—Bimatoprost—glaucoma	0.00101	0.00354	CcSEcCtD
Loperamide—Diarrhoea—Carbachol—glaucoma	0.001	0.00352	CcSEcCtD
Loperamide—Flatulence—Pilocarpine—glaucoma	0.001	0.00351	CcSEcCtD
Loperamide—Dizziness—Diclofenamide—glaucoma	0.000994	0.00349	CcSEcCtD
Loperamide—Asthenia—Methazolamide—glaucoma	0.000993	0.00348	CcSEcCtD
Loperamide—Loss of consciousness—Brimonidine—glaucoma	0.00099	0.00347	CcSEcCtD
Loperamide—Diarrhoea—Levobunolol—glaucoma	0.000988	0.00347	CcSEcCtD
Loperamide—Discomfort—Acetazolamide—glaucoma	0.000987	0.00346	CcSEcCtD
Loperamide—Angioedema—Dorzolamide—glaucoma	0.000983	0.00345	CcSEcCtD
Loperamide—Nausea—Metipranolol—glaucoma	0.00098	0.00344	CcSEcCtD
Loperamide—Dizziness—Carbachol—glaucoma	0.00097	0.0034	CcSEcCtD
Loperamide—Anaphylactic shock—Acetazolamide—glaucoma	0.000958	0.00336	CcSEcCtD
Loperamide—Headache—Carteolol—glaucoma	0.000958	0.00336	CcSEcCtD
Loperamide—Vomiting—Diclofenamide—glaucoma	0.000956	0.00335	CcSEcCtD
Loperamide—Dizziness—Levobunolol—glaucoma	0.000955	0.00335	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000953	0.00334	CcSEcCtD
Loperamide—Somnolence—Apraclonidine—glaucoma	0.000952	0.00334	CcSEcCtD
Loperamide—Pruritus—Latanoprost—glaucoma	0.000948	0.00332	CcSEcCtD
Loperamide—Rash—Diclofenamide—glaucoma	0.000948	0.00332	CcSEcCtD
Loperamide—Discomfort—Brimonidine—glaucoma	0.000948	0.00332	CcSEcCtD
Loperamide—Diarrhoea—Methazolamide—glaucoma	0.000947	0.00332	CcSEcCtD
Loperamide—Loss of consciousness—Dorzolamide—glaucoma	0.000946	0.00332	CcSEcCtD
Loperamide—Headache—Diclofenamide—glaucoma	0.000942	0.0033	CcSEcCtD
Loperamide—Dry mouth—Brimonidine—glaucoma	0.000938	0.00329	CcSEcCtD
Loperamide—Vomiting—Carbachol—glaucoma	0.000933	0.00327	CcSEcCtD
Loperamide—Rash—Carbachol—glaucoma	0.000925	0.00324	CcSEcCtD
Loperamide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000925	0.00324	CcSEcCtD
Loperamide—Dermatitis—Carbachol—glaucoma	0.000924	0.00324	CcSEcCtD
Loperamide—Fatigue—Apraclonidine—glaucoma	0.000923	0.00324	CcSEcCtD
Loperamide—Somnolence—Bimatoprost—glaucoma	0.000923	0.00324	CcSEcCtD
Loperamide—Headache—Carbachol—glaucoma	0.000919	0.00322	CcSEcCtD
Loperamide—Constipation—Apraclonidine—glaucoma	0.000916	0.00321	CcSEcCtD
Loperamide—Dyspepsia—Bimatoprost—glaucoma	0.000914	0.00321	CcSEcCtD
Loperamide—Nausea—Carteolol—glaucoma	0.000908	0.00318	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000906	0.00318	CcSEcCtD
Loperamide—Headache—Levobunolol—glaucoma	0.000905	0.00317	CcSEcCtD
Loperamide—Discomfort—Dorzolamide—glaucoma	0.000905	0.00317	CcSEcCtD
Loperamide—Nervous system disorder—Brimonidine—glaucoma	0.000902	0.00316	CcSEcCtD
Loperamide—Discomfort—Travoprost—glaucoma	0.000901	0.00316	CcSEcCtD
Loperamide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000897	0.00314	CcSEcCtD
Loperamide—Dry mouth—Dorzolamide—glaucoma	0.000896	0.00314	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000894	0.00314	CcSEcCtD
Loperamide—Loss of consciousness—Pilocarpine—glaucoma	0.000894	0.00313	CcSEcCtD
Loperamide—Skin disorder—Brimonidine—glaucoma	0.000893	0.00313	CcSEcCtD
Loperamide—Nausea—Diclofenamide—glaucoma	0.000893	0.00313	CcSEcCtD
Loperamide—Dry mouth—Travoprost—glaucoma	0.000892	0.00313	CcSEcCtD
Loperamide—Discomfort—Brinzolamide—glaucoma	0.00089	0.00312	CcSEcCtD
Loperamide—Dizziness—Latanoprost—glaucoma	0.000886	0.00311	CcSEcCtD
Loperamide—Dry mouth—Brinzolamide—glaucoma	0.000881	0.00309	CcSEcCtD
Loperamide—Vomiting—Methazolamide—glaucoma	0.00088	0.00309	CcSEcCtD
Loperamide—Anaphylactic shock—Dorzolamide—glaucoma	0.000878	0.00308	CcSEcCtD
Loperamide—Gastrointestinal pain—Apraclonidine—glaucoma	0.000876	0.00307	CcSEcCtD
Loperamide—Abdominal pain upper—Timolol—glaucoma	0.000876	0.00307	CcSEcCtD
Loperamide—Rash—Methazolamide—glaucoma	0.000873	0.00306	CcSEcCtD
Loperamide—Dermatitis—Methazolamide—glaucoma	0.000872	0.00306	CcSEcCtD
Loperamide—Nausea—Carbachol—glaucoma	0.000871	0.00306	CcSEcCtD
Loperamide—Headache—Methazolamide—glaucoma	0.000867	0.00304	CcSEcCtD
Loperamide—Nausea—Levobunolol—glaucoma	0.000858	0.00301	CcSEcCtD
Loperamide—Nervous system disorder—Travoprost—glaucoma	0.000857	0.00301	CcSEcCtD
Loperamide—Discomfort—Pilocarpine—glaucoma	0.000855	0.003	CcSEcCtD
Loperamide—Somnolence—Acetazolamide—glaucoma	0.000852	0.00299	CcSEcCtD
Loperamide—Skin disorder—Travoprost—glaucoma	0.000849	0.00298	CcSEcCtD
Loperamide—Abdominal pain—Apraclonidine—glaucoma	0.000847	0.00297	CcSEcCtD
Loperamide—Nervous system disorder—Brinzolamide—glaucoma	0.000847	0.00297	CcSEcCtD
Loperamide—Rash—Latanoprost—glaucoma	0.000845	0.00296	CcSEcCtD
Loperamide—Dermatitis—Latanoprost—glaucoma	0.000844	0.00296	CcSEcCtD
Loperamide—Dyspepsia—Acetazolamide—glaucoma	0.000843	0.00296	CcSEcCtD
Loperamide—Headache—Latanoprost—glaucoma	0.000839	0.00294	CcSEcCtD
Loperamide—Skin disorder—Brinzolamide—glaucoma	0.000839	0.00294	CcSEcCtD
Loperamide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000827	0.0029	CcSEcCtD
Loperamide—Fatigue—Acetazolamide—glaucoma	0.000826	0.0029	CcSEcCtD
Loperamide—Nausea—Methazolamide—glaucoma	0.000822	0.00288	CcSEcCtD
Loperamide—Somnolence—Brimonidine—glaucoma	0.000817	0.00287	CcSEcCtD
Loperamide—Dyspepsia—Brimonidine—glaucoma	0.000809	0.00284	CcSEcCtD
Loperamide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000794	0.00278	CcSEcCtD
Loperamide—Fatigue—Brimonidine—glaucoma	0.000793	0.00278	CcSEcCtD
Loperamide—Hypersensitivity—Apraclonidine—glaucoma	0.000789	0.00277	CcSEcCtD
Loperamide—Somnolence—Dorzolamide—glaucoma	0.000781	0.00274	CcSEcCtD
Loperamide—Dyspepsia—Dorzolamide—glaucoma	0.000773	0.00271	CcSEcCtD
Loperamide—Dyspepsia—Travoprost—glaucoma	0.00077	0.0027	CcSEcCtD
Loperamide—Asthenia—Apraclonidine—glaucoma	0.000768	0.00269	CcSEcCtD
Loperamide—Somnolence—Brinzolamide—glaucoma	0.000768	0.00269	CcSEcCtD
Loperamide—Urticaria—Acetazolamide—glaucoma	0.000761	0.00267	CcSEcCtD
Loperamide—Dyspepsia—Brinzolamide—glaucoma	0.00076	0.00266	CcSEcCtD
Loperamide—Pruritus—Apraclonidine—glaucoma	0.000758	0.00266	CcSEcCtD
Loperamide—Fatigue—Dorzolamide—glaucoma	0.000757	0.00265	CcSEcCtD
Loperamide—Gastrointestinal disorder—Travoprost—glaucoma	0.000755	0.00265	CcSEcCtD
Loperamide—Fatigue—Travoprost—glaucoma	0.000754	0.00264	CcSEcCtD
Loperamide—Constipation—Travoprost—glaucoma	0.000748	0.00262	CcSEcCtD
Loperamide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000745	0.00261	CcSEcCtD
Loperamide—Asthenia—Bimatoprost—glaucoma	0.000745	0.00261	CcSEcCtD
Loperamide—Fatigue—Brinzolamide—glaucoma	0.000744	0.00261	CcSEcCtD
Loperamide—Angioedema—Clonidine—glaucoma	0.000742	0.0026	CcSEcCtD
Loperamide—Somnolence—Pilocarpine—glaucoma	0.000738	0.00259	CcSEcCtD
Loperamide—Pruritus—Bimatoprost—glaucoma	0.000735	0.00258	CcSEcCtD
Loperamide—Immune system disorder—Betaxolol—glaucoma	0.000733	0.00257	CcSEcCtD
Loperamide—Diarrhoea—Apraclonidine—glaucoma	0.000733	0.00257	CcSEcCtD
Loperamide—Dyspepsia—Pilocarpine—glaucoma	0.00073	0.00256	CcSEcCtD
Loperamide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000718	0.00252	CcSEcCtD
Loperamide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000716	0.00251	CcSEcCtD
Loperamide—Gastrointestinal pain—Travoprost—glaucoma	0.000715	0.00251	CcSEcCtD
Loperamide—Loss of consciousness—Clonidine—glaucoma	0.000714	0.0025	CcSEcCtD
Loperamide—Constipation—Pilocarpine—glaucoma	0.00071	0.00249	CcSEcCtD
Loperamide—Dizziness—Apraclonidine—glaucoma	0.000708	0.00248	CcSEcCtD
Loperamide—Urticaria—Dorzolamide—glaucoma	0.000698	0.00245	CcSEcCtD
Loperamide—Abdominal pain—Dorzolamide—glaucoma	0.000694	0.00243	CcSEcCtD
Loperamide—Abdominal pain—Travoprost—glaucoma	0.000691	0.00242	CcSEcCtD
Loperamide—Asthenia—Acetazolamide—glaucoma	0.000687	0.00241	CcSEcCtD
Loperamide—Dizziness—Bimatoprost—glaucoma	0.000687	0.00241	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000686	0.00241	CcSEcCtD
Loperamide—Urticaria—Brinzolamide—glaucoma	0.000686	0.0024	CcSEcCtD
Loperamide—Discomfort—Clonidine—glaucoma	0.000683	0.00239	CcSEcCtD
Loperamide—Vomiting—Apraclonidine—glaucoma	0.000681	0.00239	CcSEcCtD
Loperamide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000679	0.00238	CcSEcCtD
Loperamide—Hypersensitivity—Brimonidine—glaucoma	0.000677	0.00238	CcSEcCtD
Loperamide—Dry mouth—Clonidine—glaucoma	0.000676	0.00237	CcSEcCtD
Loperamide—Dermatitis—Apraclonidine—glaucoma	0.000675	0.00237	CcSEcCtD
Loperamide—Headache—Apraclonidine—glaucoma	0.000671	0.00235	CcSEcCtD
Loperamide—Asthenia—Brimonidine—glaucoma	0.00066	0.00231	CcSEcCtD
Loperamide—Abdominal pain—Pilocarpine—glaucoma	0.000656	0.0023	CcSEcCtD
Loperamide—Diarrhoea—Acetazolamide—glaucoma	0.000656	0.0023	CcSEcCtD
Loperamide—Rash—Bimatoprost—glaucoma	0.000655	0.0023	CcSEcCtD
Loperamide—Dermatitis—Bimatoprost—glaucoma	0.000654	0.00229	CcSEcCtD
Loperamide—Pruritus—Brimonidine—glaucoma	0.000651	0.00228	CcSEcCtD
Loperamide—Headache—Bimatoprost—glaucoma	0.000651	0.00228	CcSEcCtD
Loperamide—Nervous system disorder—Clonidine—glaucoma	0.00065	0.00228	CcSEcCtD
Loperamide—Hypersensitivity—Dorzolamide—glaucoma	0.000647	0.00227	CcSEcCtD
Loperamide—Hypersensitivity—Travoprost—glaucoma	0.000644	0.00226	CcSEcCtD
Loperamide—Skin disorder—Clonidine—glaucoma	0.000644	0.00226	CcSEcCtD
Loperamide—Nausea—Apraclonidine—glaucoma	0.000636	0.00223	CcSEcCtD
Loperamide—Hypersensitivity—Brinzolamide—glaucoma	0.000636	0.00223	CcSEcCtD
Loperamide—Dizziness—Acetazolamide—glaucoma	0.000634	0.00222	CcSEcCtD
Loperamide—Asthenia—Dorzolamide—glaucoma	0.00063	0.00221	CcSEcCtD
Loperamide—Asthenia—Travoprost—glaucoma	0.000627	0.0022	CcSEcCtD
Loperamide—Pruritus—Dorzolamide—glaucoma	0.000621	0.00218	CcSEcCtD
Loperamide—Loss of consciousness—Betaxolol—glaucoma	0.000621	0.00218	CcSEcCtD
Loperamide—Asthenia—Brinzolamide—glaucoma	0.000619	0.00217	CcSEcCtD
Loperamide—Pruritus—Travoprost—glaucoma	0.000619	0.00217	CcSEcCtD
Loperamide—Nausea—Bimatoprost—glaucoma	0.000617	0.00216	CcSEcCtD
Loperamide—Hypersensitivity—Pilocarpine—glaucoma	0.000611	0.00214	CcSEcCtD
Loperamide—Pruritus—Brinzolamide—glaucoma	0.000611	0.00214	CcSEcCtD
Loperamide—Vomiting—Acetazolamide—glaucoma	0.000609	0.00214	CcSEcCtD
Loperamide—Dizziness—Brimonidine—glaucoma	0.000608	0.00213	CcSEcCtD
Loperamide—Diarrhoea—Dorzolamide—glaucoma	0.000601	0.00211	CcSEcCtD
Loperamide—Headache—Acetazolamide—glaucoma	0.0006	0.0021	CcSEcCtD
Loperamide—Immune system disorder—Timolol—glaucoma	0.000599	0.0021	CcSEcCtD
Loperamide—Diarrhoea—Travoprost—glaucoma	0.000598	0.0021	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000598	0.0021	CcSEcCtD
Loperamide—Asthenia—Pilocarpine—glaucoma	0.000595	0.00209	CcSEcCtD
Loperamide—Discomfort—Betaxolol—glaucoma	0.000595	0.00208	CcSEcCtD
Loperamide—Diarrhoea—Brinzolamide—glaucoma	0.000591	0.00207	CcSEcCtD
Loperamide—Somnolence—Clonidine—glaucoma	0.000589	0.00207	CcSEcCtD
Loperamide—Dry mouth—Betaxolol—glaucoma	0.000589	0.00206	CcSEcCtD
Loperamide—Pruritus—Pilocarpine—glaucoma	0.000587	0.00206	CcSEcCtD
Loperamide—Dizziness—Dorzolamide—glaucoma	0.000581	0.00204	CcSEcCtD
Loperamide—Rash—Brimonidine—glaucoma	0.00058	0.00203	CcSEcCtD
Loperamide—Dermatitis—Brimonidine—glaucoma	0.000579	0.00203	CcSEcCtD
Loperamide—Dizziness—Travoprost—glaucoma	0.000578	0.00203	CcSEcCtD
Loperamide—Headache—Brimonidine—glaucoma	0.000576	0.00202	CcSEcCtD
Loperamide—Gastrointestinal disorder—Clonidine—glaucoma	0.000572	0.00201	CcSEcCtD
Loperamide—Fatigue—Clonidine—glaucoma	0.000571	0.002	CcSEcCtD
Loperamide—Dizziness—Brinzolamide—glaucoma	0.000571	0.002	CcSEcCtD
Loperamide—Nausea—Acetazolamide—glaucoma	0.000569	0.002	CcSEcCtD
Loperamide—Diarrhoea—Pilocarpine—glaucoma	0.000568	0.00199	CcSEcCtD
Loperamide—Constipation—Clonidine—glaucoma	0.000567	0.00199	CcSEcCtD
Loperamide—Nervous system disorder—Betaxolol—glaucoma	0.000566	0.00198	CcSEcCtD
Loperamide—Skin disorder—Betaxolol—glaucoma	0.00056	0.00196	CcSEcCtD
Loperamide—Vomiting—Dorzolamide—glaucoma	0.000558	0.00196	CcSEcCtD
Loperamide—Rash—Dorzolamide—glaucoma	0.000554	0.00194	CcSEcCtD
Loperamide—Dermatitis—Dorzolamide—glaucoma	0.000553	0.00194	CcSEcCtD
Loperamide—Rash—Travoprost—glaucoma	0.000551	0.00193	CcSEcCtD
Loperamide—Dermatitis—Travoprost—glaucoma	0.000551	0.00193	CcSEcCtD
Loperamide—Headache—Dorzolamide—glaucoma	0.00055	0.00193	CcSEcCtD
Loperamide—Vomiting—Brinzolamide—glaucoma	0.000549	0.00192	CcSEcCtD
Loperamide—Dizziness—Pilocarpine—glaucoma	0.000549	0.00192	CcSEcCtD
Loperamide—Headache—Travoprost—glaucoma	0.000548	0.00192	CcSEcCtD
Loperamide—Nausea—Brimonidine—glaucoma	0.000546	0.00192	CcSEcCtD
Loperamide—Rash—Brinzolamide—glaucoma	0.000544	0.00191	CcSEcCtD
Loperamide—Dermatitis—Brinzolamide—glaucoma	0.000544	0.00191	CcSEcCtD
Loperamide—Gastrointestinal pain—Clonidine—glaucoma	0.000542	0.0019	CcSEcCtD
Loperamide—Headache—Brinzolamide—glaucoma	0.000541	0.0019	CcSEcCtD
Loperamide—Angioedema—Timolol—glaucoma	0.000528	0.00185	CcSEcCtD
Loperamide—Vomiting—Pilocarpine—glaucoma	0.000528	0.00185	CcSEcCtD
Loperamide—Urticaria—Clonidine—glaucoma	0.000526	0.00185	CcSEcCtD
Loperamide—Abdominal pain—Clonidine—glaucoma	0.000524	0.00184	CcSEcCtD
Loperamide—Rash—Pilocarpine—glaucoma	0.000523	0.00183	CcSEcCtD
Loperamide—Dermatitis—Pilocarpine—glaucoma	0.000523	0.00183	CcSEcCtD
Loperamide—Nausea—Dorzolamide—glaucoma	0.000522	0.00183	CcSEcCtD
Loperamide—Headache—Pilocarpine—glaucoma	0.00052	0.00182	CcSEcCtD
Loperamide—Nausea—Travoprost—glaucoma	0.000519	0.00182	CcSEcCtD
Loperamide—Nausea—Brinzolamide—glaucoma	0.000513	0.0018	CcSEcCtD
Loperamide—Dyspepsia—Betaxolol—glaucoma	0.000508	0.00178	CcSEcCtD
Loperamide—Loss of consciousness—Timolol—glaucoma	0.000508	0.00178	CcSEcCtD
Loperamide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000498	0.00175	CcSEcCtD
Loperamide—Fatigue—Betaxolol—glaucoma	0.000497	0.00174	CcSEcCtD
Loperamide—Constipation—Betaxolol—glaucoma	0.000493	0.00173	CcSEcCtD
Loperamide—Nausea—Pilocarpine—glaucoma	0.000493	0.00173	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000488	0.00171	CcSEcCtD
Loperamide—Hypersensitivity—Clonidine—glaucoma	0.000488	0.00171	CcSEcCtD
Loperamide—Discomfort—Timolol—glaucoma	0.000486	0.0017	CcSEcCtD
Loperamide—Dry mouth—Timolol—glaucoma	0.000481	0.00169	CcSEcCtD
Loperamide—Asthenia—Clonidine—glaucoma	0.000475	0.00167	CcSEcCtD
Loperamide—Anaphylactic shock—Timolol—glaucoma	0.000471	0.00165	CcSEcCtD
Loperamide—Pruritus—Clonidine—glaucoma	0.000469	0.00164	CcSEcCtD
Loperamide—Nervous system disorder—Timolol—glaucoma	0.000462	0.00162	CcSEcCtD
Loperamide—Urticaria—Betaxolol—glaucoma	0.000458	0.00161	CcSEcCtD
Loperamide—Skin disorder—Timolol—glaucoma	0.000458	0.00161	CcSEcCtD
Loperamide—Diarrhoea—Clonidine—glaucoma	0.000453	0.00159	CcSEcCtD
Loperamide—Dizziness—Clonidine—glaucoma	0.000438	0.00154	CcSEcCtD
Loperamide—Hypersensitivity—Betaxolol—glaucoma	0.000425	0.00149	CcSEcCtD
Loperamide—Vomiting—Clonidine—glaucoma	0.000421	0.00148	CcSEcCtD
Loperamide—Somnolence—Timolol—glaucoma	0.000419	0.00147	CcSEcCtD
Loperamide—Rash—Clonidine—glaucoma	0.000418	0.00146	CcSEcCtD
Loperamide—Dermatitis—Clonidine—glaucoma	0.000417	0.00146	CcSEcCtD
Loperamide—Headache—Clonidine—glaucoma	0.000415	0.00146	CcSEcCtD
Loperamide—Dyspepsia—Timolol—glaucoma	0.000415	0.00145	CcSEcCtD
Loperamide—Asthenia—Betaxolol—glaucoma	0.000414	0.00145	CcSEcCtD
Loperamide—Pruritus—Betaxolol—glaucoma	0.000408	0.00143	CcSEcCtD
Loperamide—Gastrointestinal disorder—Timolol—glaucoma	0.000407	0.00143	CcSEcCtD
Loperamide—Fatigue—Timolol—glaucoma	0.000406	0.00142	CcSEcCtD
Loperamide—Diarrhoea—Betaxolol—glaucoma	0.000395	0.00138	CcSEcCtD
Loperamide—Nausea—Clonidine—glaucoma	0.000394	0.00138	CcSEcCtD
Loperamide—Gastrointestinal pain—Timolol—glaucoma	0.000385	0.00135	CcSEcCtD
Loperamide—Dizziness—Betaxolol—glaucoma	0.000381	0.00134	CcSEcCtD
Loperamide—Urticaria—Timolol—glaucoma	0.000374	0.00131	CcSEcCtD
Loperamide—Abdominal pain—Timolol—glaucoma	0.000373	0.00131	CcSEcCtD
Loperamide—Vomiting—Betaxolol—glaucoma	0.000367	0.00129	CcSEcCtD
Loperamide—Rash—Betaxolol—glaucoma	0.000364	0.00128	CcSEcCtD
Loperamide—Dermatitis—Betaxolol—glaucoma	0.000363	0.00127	CcSEcCtD
Loperamide—Headache—Betaxolol—glaucoma	0.000361	0.00127	CcSEcCtD
Loperamide—Hypersensitivity—Timolol—glaucoma	0.000347	0.00122	CcSEcCtD
Loperamide—Nausea—Betaxolol—glaucoma	0.000343	0.0012	CcSEcCtD
Loperamide—Asthenia—Timolol—glaucoma	0.000338	0.00119	CcSEcCtD
Loperamide—Pruritus—Timolol—glaucoma	0.000333	0.00117	CcSEcCtD
Loperamide—Diarrhoea—Timolol—glaucoma	0.000322	0.00113	CcSEcCtD
Loperamide—Dizziness—Timolol—glaucoma	0.000312	0.00109	CcSEcCtD
Loperamide—Vomiting—Timolol—glaucoma	0.0003	0.00105	CcSEcCtD
Loperamide—Rash—Timolol—glaucoma	0.000297	0.00104	CcSEcCtD
Loperamide—Dermatitis—Timolol—glaucoma	0.000297	0.00104	CcSEcCtD
Loperamide—Headache—Timolol—glaucoma	0.000295	0.00104	CcSEcCtD
Loperamide—Nausea—Timolol—glaucoma	0.00028	0.000982	CcSEcCtD
Loperamide—OPRK1—Signaling Pathways—NTRK1—glaucoma	3.52e-05	0.000199	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—C3—glaucoma	3.51e-05	0.000198	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—C3—glaucoma	3.51e-05	0.000198	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—BCL2L1—glaucoma	3.5e-05	0.000197	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—BCL2L1—glaucoma	3.5e-05	0.000197	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.48e-05	0.000196	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TXN—glaucoma	3.39e-05	0.000191	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—BAD—glaucoma	3.28e-05	0.000185	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NGF—glaucoma	3.26e-05	0.000184	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CDKN2B—glaucoma	3.24e-05	0.000183	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—BAD—glaucoma	3.17e-05	0.000179	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—BAD—glaucoma	3.17e-05	0.000179	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HDAC9—glaucoma	3.16e-05	0.000178	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—BAD—glaucoma	3.15e-05	0.000178	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NGFR—glaucoma	3.13e-05	0.000177	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EDN1—glaucoma	3.11e-05	0.000176	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTT1—glaucoma	3.1e-05	0.000175	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—C3—glaucoma	3.1e-05	0.000175	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.09e-05	0.000174	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.06e-05	0.000173	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HDAC9—glaucoma	3.05e-05	0.000172	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HDAC9—glaucoma	3.05e-05	0.000172	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—BAD—glaucoma	3.04e-05	0.000172	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—BAD—glaucoma	3.04e-05	0.000172	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTT1—glaucoma	3.02e-05	0.00017	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.98e-05	0.000168	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NTRK1—glaucoma	2.97e-05	0.000168	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—glaucoma	2.97e-05	0.000167	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TXN—glaucoma	2.95e-05	0.000167	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS3—glaucoma	2.93e-05	0.000165	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTT1—glaucoma	2.92e-05	0.000165	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTT1—glaucoma	2.92e-05	0.000165	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—APOE—glaucoma	2.89e-05	0.000163	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NGF—glaucoma	2.86e-05	0.000161	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CAV1—glaucoma	2.86e-05	0.000161	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS3—glaucoma	2.83e-05	0.00016	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS3—glaucoma	2.83e-05	0.00016	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CA1—glaucoma	2.82e-05	0.000159	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TXN—glaucoma	2.78e-05	0.000157	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EDN1—glaucoma	2.76e-05	0.000155	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CDKN2B—glaucoma	2.74e-05	0.000155	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CTSA—glaucoma	2.73e-05	0.000154	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FN1—glaucoma	2.72e-05	0.000154	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—C3—glaucoma	2.72e-05	0.000153	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—BAD—glaucoma	2.69e-05	0.000152	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EDN1—glaucoma	2.67e-05	0.00015	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EDN1—glaucoma	2.67e-05	0.00015	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.63e-05	0.000148	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EDN1—glaucoma	2.63e-05	0.000148	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTT1—glaucoma	2.63e-05	0.000148	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CA2—glaucoma	2.58e-05	0.000146	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—APOE—glaucoma	2.53e-05	0.000143	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CAV1—glaucoma	2.51e-05	0.000141	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1A—glaucoma	2.5e-05	0.000141	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CYP1B1—glaucoma	2.47e-05	0.00014	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ABCA1—glaucoma	2.47e-05	0.00014	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SMO—glaucoma	2.47e-05	0.000139	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN2B—glaucoma	2.42e-05	0.000137	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1A—glaucoma	2.42e-05	0.000137	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1A—glaucoma	2.42e-05	0.000137	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NGF—glaucoma	2.42e-05	0.000136	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—C3—glaucoma	2.41e-05	0.000136	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CYP1B1—glaucoma	2.41e-05	0.000136	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ABCA1—glaucoma	2.41e-05	0.000136	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SMO—glaucoma	2.39e-05	0.000135	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SMO—glaucoma	2.39e-05	0.000135	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FN1—glaucoma	2.39e-05	0.000135	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—BAD—glaucoma	2.36e-05	0.000133	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN2B—glaucoma	2.34e-05	0.000132	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN2B—glaucoma	2.34e-05	0.000132	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—C3—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—C3—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ABCA1—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CYP1B1—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ABCA1—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CYP1B1—glaucoma	2.33e-05	0.000131	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—C3—glaucoma	2.3e-05	0.00013	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTT1—glaucoma	2.29e-05	0.000129	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CDKN1B—glaucoma	2.28e-05	0.000129	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NTRK2—glaucoma	2.26e-05	0.000127	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CDKN1B—glaucoma	2.21e-05	0.000125	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CDKN1B—glaucoma	2.21e-05	0.000125	CbGpPWpGaD
Loperamide—CALM3—Immune System—C3—glaucoma	2.2e-05	0.000124	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CDKN1B—glaucoma	2.19e-05	0.000124	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NTRK2—glaucoma	2.18e-05	0.000123	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NTRK2—glaucoma	2.18e-05	0.000123	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOS3—glaucoma	2.16e-05	0.000122	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTT1—glaucoma	2.16e-05	0.000122	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOE—glaucoma	2.14e-05	0.000121	CbGpPWpGaD
Loperamide—CALM2—Immune System—C3—glaucoma	2.13e-05	0.00012	CbGpPWpGaD
Loperamide—CALM1—Immune System—C3—glaucoma	2.13e-05	0.00012	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CDKN1B—glaucoma	2.12e-05	0.00012	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CDKN1B—glaucoma	2.12e-05	0.00012	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.12e-05	0.00012	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CAV1—glaucoma	2.12e-05	0.00012	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—VEGFA—glaucoma	2.11e-05	0.000119	CbGpPWpGaD
Loperamide—CALM3—Immune System—BCL2L1—glaucoma	2.11e-05	0.000119	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ABCA1—glaucoma	2.09e-05	0.000118	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CYP1B1—glaucoma	2.09e-05	0.000118	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—VEGFA—glaucoma	2.04e-05	0.000115	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—VEGFA—glaucoma	2.04e-05	0.000115	CbGpPWpGaD
Loperamide—CALM1—Immune System—BCL2L1—glaucoma	2.04e-05	0.000115	CbGpPWpGaD
Loperamide—CALM2—Immune System—BCL2L1—glaucoma	2.04e-05	0.000115	CbGpPWpGaD
Loperamide—CALM3—Disease—MTHFR—glaucoma	2.03e-05	0.000115	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FN1—glaucoma	2.02e-05	0.000114	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—BAD—glaucoma	1.99e-05	0.000112	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTM1—glaucoma	1.98e-05	0.000112	CbGpPWpGaD
Loperamide—CALM1—Disease—MTHFR—glaucoma	1.96e-05	0.000111	CbGpPWpGaD
Loperamide—CALM2—Disease—MTHFR—glaucoma	1.96e-05	0.000111	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NGFR—glaucoma	1.94e-05	0.000109	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTM1—glaucoma	1.92e-05	0.000109	CbGpPWpGaD
Loperamide—CALM3—Immune System—BAD—glaucoma	1.91e-05	0.000108	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOS3—glaucoma	1.9e-05	0.000107	CbGpPWpGaD
Loperamide—CALM3—Disease—APOE—glaucoma	1.89e-05	0.000107	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NGFR—glaucoma	1.87e-05	0.000106	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NGFR—glaucoma	1.87e-05	0.000106	CbGpPWpGaD
Loperamide—CALM3—Disease—CAV1—glaucoma	1.87e-05	0.000106	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CDKN1B—glaucoma	1.87e-05	0.000106	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTM1—glaucoma	1.86e-05	0.000105	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTM1—glaucoma	1.86e-05	0.000105	CbGpPWpGaD
Loperamide—CALM1—Immune System—BAD—glaucoma	1.85e-05	0.000104	CbGpPWpGaD
Loperamide—CALM2—Immune System—BAD—glaucoma	1.85e-05	0.000104	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NTRK1—glaucoma	1.84e-05	0.000104	CbGpPWpGaD
Loperamide—CALM2—Disease—APOE—glaucoma	1.83e-05	0.000103	CbGpPWpGaD
Loperamide—CALM1—Disease—APOE—glaucoma	1.83e-05	0.000103	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ABCA1—glaucoma	1.82e-05	0.000103	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP1B1—glaucoma	1.82e-05	0.000103	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TXN—glaucoma	1.82e-05	0.000103	CbGpPWpGaD
Loperamide—CALM2—Disease—CAV1—glaucoma	1.81e-05	0.000102	CbGpPWpGaD
Loperamide—CALM1—Disease—CAV1—glaucoma	1.81e-05	0.000102	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NTRK1—glaucoma	1.78e-05	0.0001	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NTRK1—glaucoma	1.78e-05	0.0001	CbGpPWpGaD
Loperamide—CALM3—Disease—BAD—glaucoma	1.76e-05	9.94e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—glaucoma	1.75e-05	9.86e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—glaucoma	1.73e-05	9.79e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCA1—glaucoma	1.72e-05	9.7e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYP1B1—glaucoma	1.72e-05	9.7e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—BAD—glaucoma	1.7e-05	9.62e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—BAD—glaucoma	1.7e-05	9.62e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—glaucoma	1.7e-05	9.6e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN2B—glaucoma	1.7e-05	9.57e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTM1—glaucoma	1.67e-05	9.45e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—glaucoma	1.65e-05	9.28e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—glaucoma	1.65e-05	9.28e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CDKN1B—glaucoma	1.64e-05	9.27e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN2B—glaucoma	1.64e-05	9.26e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN2B—glaucoma	1.64e-05	9.26e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EDN1—glaucoma	1.63e-05	9.18e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—glaucoma	1.63e-05	9.18e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CAV1—glaucoma	1.61e-05	9.09e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—glaucoma	1.6e-05	9.04e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—glaucoma	1.59e-05	8.99e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—glaucoma	1.58e-05	8.93e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EDN1—glaucoma	1.57e-05	8.89e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EDN1—glaucoma	1.57e-05	8.89e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CAV1—glaucoma	1.57e-05	8.85e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VEGFA—glaucoma	1.56e-05	8.79e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—glaucoma	1.54e-05	8.69e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—glaucoma	1.54e-05	8.69e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—glaucoma	1.53e-05	8.64e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—glaucoma	1.53e-05	8.64e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—glaucoma	1.52e-05	8.58e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CAV1—glaucoma	1.52e-05	8.56e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CAV1—glaucoma	1.52e-05	8.56e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NGF—glaucoma	1.5e-05	8.44e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—glaucoma	1.48e-05	8.35e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTM1—glaucoma	1.46e-05	8.23e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NGF—glaucoma	1.45e-05	8.16e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NGF—glaucoma	1.45e-05	8.16e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—C3—glaucoma	1.42e-05	8.02e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—glaucoma	1.42e-05	7.99e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTT1—glaucoma	1.41e-05	7.96e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CDKN1B—glaucoma	1.39e-05	7.83e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—glaucoma	1.38e-05	7.77e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—C3—glaucoma	1.38e-05	7.76e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—C3—glaucoma	1.38e-05	7.76e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTM1—glaucoma	1.37e-05	7.75e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—glaucoma	1.37e-05	7.73e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—glaucoma	1.37e-05	7.73e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VEGFA—glaucoma	1.37e-05	7.71e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAV1—glaucoma	1.36e-05	7.7e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDKN1B—glaucoma	1.33e-05	7.5e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—glaucoma	1.32e-05	7.47e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CAV1—glaucoma	1.31e-05	7.4e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—glaucoma	1.3e-05	7.31e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—glaucoma	1.29e-05	7.27e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—glaucoma	1.29e-05	7.25e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDKN1B—glaucoma	1.29e-05	7.25e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDKN1B—glaucoma	1.29e-05	7.25e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—glaucoma	1.28e-05	7.23e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—glaucoma	1.28e-05	7.23e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CAV1—glaucoma	1.27e-05	7.16e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CAV1—glaucoma	1.27e-05	7.16e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—glaucoma	1.25e-05	7.07e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—glaucoma	1.25e-05	7.07e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FN1—glaucoma	1.25e-05	7.04e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—BAD—glaucoma	1.23e-05	6.96e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN1B—glaucoma	1.23e-05	6.92e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—glaucoma	1.22e-05	6.88e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—glaucoma	1.21e-05	6.85e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FN1—glaucoma	1.21e-05	6.81e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FN1—glaucoma	1.21e-05	6.81e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—glaucoma	1.2e-05	6.77e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—BAD—glaucoma	1.19e-05	6.73e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—BAD—glaucoma	1.19e-05	6.73e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAV1—glaucoma	1.19e-05	6.71e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN1B—glaucoma	1.19e-05	6.7e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN1B—glaucoma	1.19e-05	6.7e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—glaucoma	1.19e-05	6.69e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—glaucoma	1.18e-05	6.64e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—glaucoma	1.15e-05	6.51e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—glaucoma	1.15e-05	6.47e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—glaucoma	1.15e-05	6.47e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—glaucoma	1.13e-05	6.38e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP1B1—glaucoma	1.12e-05	6.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCA1—glaucoma	1.12e-05	6.34e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAV1—glaucoma	1.12e-05	6.32e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—glaucoma	1.11e-05	6.29e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—glaucoma	1.08e-05	6.12e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—glaucoma	1.05e-05	5.92e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—glaucoma	1.05e-05	5.92e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—glaucoma	1.03e-05	5.82e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—glaucoma	1.03e-05	5.82e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—glaucoma	9.92e-06	5.6e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—glaucoma	9.59e-06	5.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—glaucoma	9.59e-06	5.41e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—glaucoma	9.44e-06	5.32e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—glaucoma	8.99e-06	5.07e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—glaucoma	8.99e-06	5.07e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—glaucoma	8.72e-06	4.92e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1B—glaucoma	8.59e-06	4.85e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—glaucoma	8.47e-06	4.78e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1B—glaucoma	8.31e-06	4.69e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1B—glaucoma	8.31e-06	4.69e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—glaucoma	8.22e-06	4.64e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—glaucoma	7.96e-06	4.49e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—glaucoma	7.94e-06	4.48e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—glaucoma	7.75e-06	4.37e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—glaucoma	7.7e-06	4.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—glaucoma	7.7e-06	4.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—glaucoma	7.39e-06	4.17e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAV1—glaucoma	7.32e-06	4.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—glaucoma	7.15e-06	4.03e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—glaucoma	6.91e-06	3.9e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—glaucoma	6.91e-06	3.9e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—glaucoma	5.54e-06	3.12e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—glaucoma	5.4e-06	3.05e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—glaucoma	5.22e-06	2.95e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—glaucoma	5.22e-06	2.95e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—glaucoma	5.07e-06	2.86e-05	CbGpPWpGaD
